What medications are used to treat altitude sickness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Altitude Sickness

For prevention and treatment of altitude sickness, acetazolamide is the first-line medication, with dexamethasone and nifedipine serving as important alternatives for specific altitude-related conditions. 1

Primary Medications for Altitude Sickness

Acetazolamide

  • Mechanism: Carbonic anhydrase inhibitor that increases ventilation and arterial oxygenation
  • Dosing for prevention:
    • 125-250 mg twice daily
    • Start 24 hours before ascent and continue for 2-3 days at high altitude 2, 3
    • For rapid ascents to elevations >3500m (military/emergency personnel): Higher doses (500-750 mg/day) may be more effective 3
  • Efficacy: Reduces AMS symptoms by 45% in unselected groups 1
  • Benefits:
    • Improves arterial oxygen saturation
    • Reduces headache, nausea, vomiting, and weakness
    • Reduces peripheral edema
    • Can lower high-altitude-induced blood pressure increases by 7-10 mmHg 1

Dexamethasone

  • Primary use: For prevention and treatment of high-altitude cerebral edema (HACE)
  • Dosing: First-line treatment for severe/malignant forms of acute mountain sickness 4
  • Benefits: Reduces AMS symptoms partly through euphoric effects 5
  • Note: Alternative to acetazolamide for those with sulfa allergies

Nifedipine

  • Primary use: Prevention and treatment of high-altitude pulmonary edema (HAPE)
  • Mechanism: Pulmonary vasodilator that reduces pulmonary hypertension 1, 4
  • Dosing: Extended-release formulation, started with ascent and continued for 3-4 days after arrival at terminal altitude 1
  • Evidence: In a placebo-controlled RCT, nifedipine reduced HAPE incidence from 7/11 (placebo) to 1/10 (treated) 1

PDE5 Inhibitors

  • Options: Tadalafil, sildenafil
  • Use: Alternative to nifedipine for HAPE prevention
  • Caution: Tadalafil has been associated with severe acute mountain sickness in some subjects 1

Treatment Algorithm

  1. For prevention of AMS (standard ascent):

    • Acetazolamide 125-250 mg twice daily, starting 24 hours before ascent
    • Optimal timing: Begin at least 2 days before arrival at high altitude for better efficacy 6
  2. For prevention of AMS (rapid ascent >3500m):

    • Acetazolamide 500-750 mg/day, starting within 24 hours of altitude exposure 3
  3. For prevention of HAPE in susceptible individuals:

    • Nifedipine (extended-release) started with ascent and continued for 3-4 days
    • Alternatives: Tadalafil or sildenafil (with caution)
  4. For treatment of established AMS:

    • Descend to lower altitude (primary treatment)
    • Supplemental oxygen
    • Acetazolamide 500 mg/day if descent not possible 4
  5. For treatment of HACE:

    • Immediate descent (critical)
    • Dexamethasone (first-line medication)
    • Supplemental oxygen
  6. For treatment of HAPE:

    • Immediate descent to lower altitude
    • Supplemental oxygen
    • Nifedipine

Important Clinical Considerations

  • Non-pharmacological prevention: Slow ascent (300-600 m/day above 2500m) is the most effective prevention 1, 4
  • Rest days: Consider a rest day for every 600-1200m gained 1
  • Avoid exertion: Delay vigorous physical activity until acclimatized 1
  • Contraindications: Acetazolamide may cause transient myopic shift; patients should be aware of this side effect 1
  • Side effects of acetazolamide: Paresthesia, vertigo, unpleasant taste 1
  • Monitoring: For patients with cardiovascular conditions, blood pressure monitoring is recommended before and during high-altitude sojourns 1

Special Populations

  • Hypertensive patients: Well-controlled hypertensive patients may reach very high altitudes (>4000m) with adequate medical therapy 1
  • Patients with pulmonary hypertension: Consider supplemental oxygen when exposed to altitudes >1500-2000m 1
  • Children with congenital heart disease: May be more susceptible to HAPE; consider preventive measures 1

Remember that immediate descent to lower altitude is the primary and most effective treatment for all severe forms of altitude sickness, with medications serving as adjunctive therapy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Mountaineering and altitude sickness].

Therapeutische Umschau. Revue therapeutique, 2001

Research

Acetazolamide and high altitude diseases.

International journal of sports medicine, 1992

Research

Acetazolamide pre-treatment before ascending to high altitudes: when to start?

International journal of clinical and experimental medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.